OOIR: Observatory of International Research

Papers

(The H4-Index of mAbs is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features	273
BERT2DAb: a pre-trained model for antibody representation based on amino acid sequences and 2D-structure	178
Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb	95
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice	70
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance	64
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework	61
Efficient production of bispecific antibody by FAST-Ig ^TM and its application to NXT007 for the treatment of hemophilia A	58
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C _H 1-C _λ interfac	51
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure	47
Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms	40
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries	37
Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering	36
Development of T-cell engagers selective for cells co-expressing two antigens	33
A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies	32
Engineering death resistance in CHO cells for improved perfusion culture	31
Phenotypic whole-cell screening identifies a protective carbohydrate epitope on Klebsiella pneumoniae	31
In silico prediction of post-translational modifications in therapeutic antibodies	29
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics	28
A strategy for the efficient construction of anti-PD1-based bispecific antibodies with desired IgG-like properties	28
In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom	27
A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation	27
Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats	26
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties	25
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4 ⁺ T cell interl	24